Geffen Residence & Renewal Ltd (TLV:GEFR)

CTI BioPharma Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.65	14.47	31.06	1.66	11.55	5
Cash & Short-Term Investments	3.65	14.47	31.06	1.66	11.55	5
Cash Growth	-88.24%	-53.41%	1775.36%	-85.66%	131.16%	858.92%
Accounts Receivable	-	-	-	-	0.06	1.24
Other Receivables	8.02	1.29	1.95	0.24	7.79	10.62
Receivables	8.02	1.29	1.95	0.24	7.84	11.86
Inventory	10.11	8.26	-	-	1.99	5.02
Prepaid Expenses	-	0.24	0.3	0.3	0.32	0.24
Other Current Assets	-	2.29	5.36	2.51	3.17	4.55
Total Current Assets	21.78	26.54	38.66	4.7	24.88	26.67
Property, Plant & Equipment	0.94	1	0.79	0.69	12.11	15.94
Goodwill	-	-	-	-	-	2.03
Other Intangible Assets	-	-	-	-	3.54	3.78
Long-Term Deferred Tax Assets	2.7	2.26	1.2	-	-	2.1
Other Long-Term Assets	75.08	72.5	65.15	5.27	-	-
Total Assets	100.5	102.3	105.8	10.66	40.53	50.52
Accounts Payable	0.01	0.02	0.03	0.07	0.39	3.34
Accrued Expenses	-	2.46	2.7	0.56	1.56	2.03
Short-Term Debt	-	-	-	3.01	-	1
Current Portion of Long-Term Debt	-	-	-	-	3.72	3.61
Current Portion of Leases	0.09	0.09	-	0.15	2.01	0.9
Other Current Liabilities	2.18	-	-	2.43	3.61	3.13
Total Current Liabilities	2.28	2.58	2.74	6.23	11.29	14.01
Long-Term Debt	45.13	44.51	45.28	-	-	-
Long-Term Leases	0.19	0.22	-	0.03	4.77	9.67
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.01
Other Long-Term Liabilities	-	0.49	-	-	-	-
Total Liabilities	47.61	47.79	48.01	6.26	16.06	23.69
Additional Paid-In Capital	75.09	75.09	73.68	15.81	15.13	3.54
Retained Earnings	-56.94	-55.2	-50.13	-43.22	-23.13	-9.71
Comprehensive Income & Other	25.5	25.36	24.87	31.8	32.47	31.5
Total Common Equity	43.65	45.25	48.42	4.4	24.47	25.33
Minority Interest	9.24	9.27	9.37	-	-	1.5
Shareholders' Equity	52.89	54.52	57.79	4.4	24.47	26.83
Total Liabilities & Equity	100.5	102.3	105.8	10.66	40.53	50.52
Total Debt	45.42	44.82	45.28	3.2	10.5	15.18
Net Cash (Debt)	-41.77	-30.35	-14.22	-1.54	1.05	-10.19
Net Cash Per Share	-0.19	-0.14	-0.07	-0.02	0.01	-0.14
Filing Date Shares Outstanding	216.04	218.12	215.64	99.39	99.39	84.45
Total Common Shares Outstanding	216.04	218.12	215.64	99.39	99.39	84.45
Working Capital	19.5	23.96	35.92	-1.53	13.59	12.66
Book Value Per Share	0.20	0.21	0.22	0.04	0.25	0.30
Tangible Book Value	43.65	45.25	48.42	4.4	20.93	19.53
Tangible Book Value Per Share	0.20	0.21	0.22	0.04	0.21	0.23
Machinery	-	-	-	-	1.08	2.91
Leasehold Improvements	-	-	-	-	0.4	0.19

Updated Aug 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.